| [1] |
中国高血压防治指南修订委员会, 高血压联盟(中国, 中国医疗保健国际交流促进会高血压分会, 等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志, 2024, 32(7): 603-700. doi:10.16439/j.issn.1673-7245.2024.07.002
|
| [2] |
国家心血管病中心, 国家基本公共卫生服务项目基层高血压管理办公室, 国家基层高血压管理专家委员会, 等. 国家基层高血压防治管理指南2020版[J]. 中国循环杂志, 2021, 36(3): 209-20. doi:10.12037/YXQY.2021.04-06
|
| [3] |
Melgarejo JD, Vernooij MW, Ikram MA, et al. Intracranial carotid arteriosclerosis mediates the association between blood pressure and cerebral small vessel disease[J]. Hypertension, 2023, 80(3): 618-28. doi:10.1161/HYPERTENSIONAHA.122.20434
|
| [4] |
关 双, 徐 蕊, 刘 骏, 等. 脑小血管病诊治的研究进展[J]. 医学综述, 2019, 25(23): 4696-701. doi:10.3969/j.issn.1006-2084.2019.23.019
|
| [5] |
Zhang Q, Jia M, Wang YF, et al. Cell death mechanisms in cerebral ischemia-reperfusion injury[J]. Neurochem Res, 2022, 47(12): 3525-42. doi:10.1007/s11064-022-03697-8
|
| [6] |
Wang CY, Chao CH. p53-mediated indirect regulation on cellular metabolism: from the mechanism of pathogenesis to the development of cancer therapeutics[J]. Front Oncol, 2022, 12: 895112. doi:10.3389/fonc.2022.895112
|
| [7] |
Aubrey BJ, Kelly GL, Janic A, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?[J]. Cell Death Differ, 2018, 25(1): 104-13. doi:10.1038/CDD.2017.169
|
| [8] |
Chan GH, Chan E, Kwok CT, et al. The role of p53 in the alternation of vascular functions[J]. Front Pharmacol, 2022, 13: 981152. doi:10.3389/fphar.2022.981152
|
| [9] |
王 博, 张晓明, 吴 松, 等. 标本配穴电针预处理对脑缺血再灌注损伤大鼠海马神经元p53与caspase-3表达的影响[J]. 中国针灸, 2019, 39(9): 957-62.
|
| [10] |
Brockhaus K, Böhm MRR, Melkonyan H, et al. Age-related beta-synuclein alters the p53/Mdm2 pathway and induces the apoptosis of brain microvascular endothelial cells in vitro [J]. Cell Transplant, 2018, 27(5): 796-813. doi:10.1177/0963689718755706
|
| [11] |
Gu ZT, Wang H, Li L, et al. Heat stress induces apoptosis through transcription-independent p53-mediated mitochondrial pathways in human umbilical vein endothelial cell[J]. Sci Rep, 2014, 4: 4469. doi:10.1038/srep04469
|
| [12] |
Cui XP, Pan GP, Chen Y, et al. The p53 pathway in vasculature revisited: a therapeutic target for pathological vascular remodeling[J]? Pharmacol Res, 2021, 169: 105683. doi:10.1016/j.phrs.2021.105683
|
| [13] |
Vecino R, Burguete MC, Jover-Mengual T, et al. The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia[J]. Sci Rep, 2018, 8: 1610. doi:10.1038/s41598-018-19921-x
|
| [14] |
陈晓萍, 程 瑛, 刘慧馨, 等. 基于代谢组学研究清达颗粒减轻高血压所致心脏损伤的生物学机制[J]. 中国中医基础医学杂志, 2023, 29(1): 79-85, 182.
|
| [15] |
蔡巧燕, 许瑶瑶, 林雨星, 等. 清达颗粒通过调控miR-124/STAT3信号轴减轻自发性高血压大鼠脑损伤[J]. 南方医科大学学报, 2025, 45(1): 18-26. doi:10.12122/j.issn.1673-4254.2025.01.03
|
| [16] |
赵春雨, 张 铃, 贾沛芝, 等. 清达颗粒对血管紧张素Ⅱ诱导的高血压小鼠心脏损伤的保护作用[J]. 福建中医药, 2023, 54(11): 25-9.
|
| [17] |
袁俊亮, 王双坤, 顾 华, 等. 脑小血管病的发病机制研究进展[J]. 中华老年心脑血管病杂志, 2018, 20(1): 102-4. doi:10.3969/j.issn.1009-0126.2018.01.027
|
| [18] |
Gao Y, Li D, Lin JW, et al. Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets[J]. Front Aging Neurosci, 2022, 14: 961661. doi:10.3389/fnagi.2022.961661
|
| [19] |
Nam KW, Kwon HM, Jeong HY, et al. Cerebral small vessel disease and stage 1 hypertension defined by the 2017 American college of cardiology/American heart association guidelines[J]. Hypertension, 2019, 73(6): 1210-6. doi:10.1161/hypertensionaha.119.12830
|
| [20] |
Iadecola C, Yaffe K, Biller J, et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association[J]. Hypertension, 2016, 68(6): e67-94. doi:10.1161/hyp.0000000000000053
|
| [21] |
Pragnąca A, Antolak A, Krysiak ZJ, et al. Marker-independent vibrational spectroscopy imaging recognizes the hypoxia effect in the human brain endothelium[J]. Sci Rep, 2025, 15(1): 26112. doi:10.1038/s41598-025-11000-2
|
| [22] |
Zhang Y, Wang T, Yang K, et al. Cerebral microvascular endothelial cell apoptosis after ischemia: role of enolase-phosphatase 1 activation and aci-reductone dioxygenase 1 translocation[J]. Front Mol Neurosci, 2016, 9: 79. doi:10.3389/fnmol.2016.00079
|
| [23] |
杨 波, 刘曙艳, 王 林, 等. miR-150-5p对脑小血管病大鼠脑微血管内皮细胞凋亡的影响[J]. 中国老年学杂志, 2023, 43(19): 4773-7. doi:10.3969/j.issn.1005-9202.2023.19.045
|
| [24] |
黄武松, 刘武平, 褚剑锋. 清达颗粒治疗肝火亢盛型1级高血压临床观察[J]. 山西中医, 2020, 36(10): 14-7. doi:10.3969/j.issn.1000-7156.2020.10.005
|
| [25] |
王志昊, 祝 娜, 唐茂红, 等. 天麻素与薯蓣皂苷元配伍对大鼠缺氧损伤脑微血管内皮细胞的保护作用[J]. 医药导报, 2024, 43(5): 667-79.
|
| [26] |
李 世. 黄芩苷对糖氧剥夺诱导内皮细胞凋亡与坏死的保护作用[D]. 广州: 广州中医药大学, 2015.
|
| [27] |
张晓娟, 左冬冬, 于孙婉琪. 钩藤化学成分和药理作用研究进展[J]. 中医药信息, 2024, 41(2): 81-6.
|
| [28] |
Yin T, Zhang H, Liu XF, et al. Elucidating the anti-hypertensive mechanisms of Uncaria rhynchophylla-Alisma plantago-Aquatica L: an integrated network pharmacology, cluster analysis, and molecular docking approach[J]. Front Chem, 2024, 12: 1356458. doi:10.3389/fchem.2024.1356458
|
| [29] |
黄 华, 齐书妍, 张 昆, 等. 甲基莲心碱抑制NLRP3炎性小体的活化缓解脑缺血再灌注大鼠脑组织损伤和免疫紊乱[J]. 免疫学杂志, 2021, 37(8): 704-9. doi:10.13431/j.cnki.immunol.j.20210098
|
| [30] |
林浩伟. 清达颗粒抑制NOX2/NLRP3信号通路改善高血压脑微血管内皮功能障碍的作用机制研究[D]. 福州: 福建中医药大学, 2025.
|
| [31] |
Foulquier S, Namsolleck P, Van Hagen BT, et al. Hypertension-induced cognitive impairment: insights from prolonged angiotensin II infusion in mice[J]. Hypertens Res, 2018, 41(10): 817-27. doi:10.1038/s41440-018-0090-9
|
| [32] |
French SR, Meyer BP, Arias JC, et al. Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia[J]. Alzheimers Dement, 2025, 21(3): e70104. doi:10.1002/alz.70104
|
| [33] |
Markus HS, de Leeuw FE. Cerebral small vessel disease: Recent advances and future directions[J]. Int J Stroke, 2023, 18(1): 4-14. doi:10.1177/17474930221144911
|
| [34] |
王 丹, 王瑶瑶, 瞿金念, 等. miR-211-5p在原发性高血压患者血清中的表达及对血管内皮细胞凋亡和炎性反应的影响[J]. 中国循证心血管医学杂志, 2022, 14(12): 1476-80. doi:10.3969/j.issn.1674-4055.2022.12.17
|
| [35] |
Yang J, Xiao C, Yi M, et al. Reduced endothelial TAK1 impairs vascular integrity in cerebral small vessel disease via the RIPK1-MLKL signalling pathway[J]. Stroke Vasc Neurol, 2025: svn-2025-004469. doi:10.1136/svn-2025-004469
|
| [36] |
Shou XL, Wang BZ, Zhou RF, et al. Baicalin suppresses hypoxia-reoxygenation-induced arterial endothelial cell apoptosis via suppressing PKCδ/p53 signaling[J]. Med Sci Monit, 2017, 23: 6057-63. doi:10.12659/MSM.907989
|
| [37] |
Zheng XY, Guo C, Peng J, et al. Baicalein inhibits proliferation, migration, and invasion of mesothelioma cells through the p53-FOXM1 signaling axis[J]. Cancer Manag Res, 2025, 17: 3197-209. doi:10.2147/CMAR.S551351
|
| [38] |
Lee HJ, Oh SY, Jo I. Zearalenone induces endothelial cell apoptosis through activation of a cytosolic Ca2+/ERK1/2/p53/caspase 3 signaling pathway[J]. Toxins, 2021, 13(3): 187. doi:10.3390/toxins13030187
|
| [39] |
Xie YY, Lu YW, Yu GR. The protective effects of hyperoside on Ang II-mediated apoptosis of bEnd.3 cells and injury of blood-brain barrier model in vitro [J]. BMC Complement Med Ther, 2022, 22(1): 157. doi:10.1186/s12906-022-03635-9
|
| [40] |
Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis[J]. J Cell Biol, 2022, 221(6): e202201159. doi:10.1083/jcb.202201159
|
| [41] |
马 莉, 董园振, 李良勇. 脑络通颗粒对脑缺血再灌注损伤大鼠凋亡及PRMT5、p53的影响[J]. 中医药临床杂志, 2024, 36(1): 124-9.
|
| [42] |
Jiang GL, Wu HY, Hu YQ, et al. Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade[J]. Cell Mol Neurobiol, 2014, 34(4): 591-602. doi:10.1007/s10571-014-0043-z
|
| [43] |
雷 琦, 朱婷鸽, 何进伟, 等. 异钩藤碱对癫痫大鼠SIRT1/p53/caspase-3通路及海马神经元凋亡的影响[J]. 中国免疫学杂志, 2022, 38(18): 2205-8. doi:10.3969/j.issn.1000-484X.2022.18.006
|